Skip to main content

Table 5 Association of chronic diseases, age, gender, period of follow-up and CD4+ cell count with per capita cost of care for HIV+ subjects using multivariate regression models

From: The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population

 

Per capita cost € (95 % CI)

p-value

Age (per year)

36.1 (24.5–47.8)

<0.001

Gender (male vs female)

−12.5 (−198.6–173.6)

0.895

Period of follow-up

 2003–2005

Ref

 

 2006–2008

1473.4 (1215.8–1731.0)

<0.001

 2009–2011

2293.9 (2054.2–2533.6)

<0.001

 2012–2014

1453.0 (1207.8–1698.2)

<0.001

CD4+ cell count

  ≥ 500

Ref

 

 350–499

1272.0 (939.0–1605.1)

<0.001

 200–349

1082.6 (864.7–1300.4)

<0.001

  < 200

2452.3 (2238.7–2666.0)

<0.001

Prevalence of chronic diseasesa

 Cardio-cerebrovascular diseases (yes vs no)

2087.8 (1736.1–2439.5)

<0.001

 Liver diseases (yes vs no)

4388.8 (3786.0–4991.7)

<0.001

 Dyslipidemia (yes vs no)

1003.4 (593.2–1413.5)

<0.001

 Diabetes (yes vs no)

1701.4 (1125.0–2277.8)

<0.001

 Cancer (yes vs no)

7557.6 (6737.0–8378.2)

<0.001

 Gastrointestinal diseases (yes vs no)

3756.8 (2797.7–4715.8)

<0.001

 Neuropathies (yes vs no)

2767.6 (2081.9–3453.3)

<0.001

 Serious psychiatric diseases (yes vs no)

8172.2 (7056.0–9288.5)

<0.001

 Chronic respiratory diseases (yes vs no)

4103.3 (3192.4–5014.1)

<0.001

 Kidney failure (yes vs no)

13665.3 (11075.2–16255.5)

<0.001

 At least one chronic disease (yes vs no)

3699.7 (3509.9–3889.5)

<0.001

  1. amodel adjusted for age, gender, period of follow-up, CD4 cell count. Abbreviation: CI confidence interval